Home
Home

cervical cancer

Merck, Glaxo Reduce HPV Vaccine Prices in Poorest Regions

Merck, Glaxo Reduce HPV Vaccine Prices in Poorest Regions
Bloomberg

Trovagene launches easier test for HPV infection

Trovagene launches easier test for HPV infection
Yahoo/AP

Advaxis Vs. Inovio: A Head To Head Comparison Of 2 Cervical Cancer Vaccines

Advaxis Vs. Inovio: A Head To Head Comparison Of 2 Cervical Cancer Vaccines
Seeking Alpha

Cancers Linked to HPV Rise in U.S. on Low Vaccine Use

Cancers Linked to HPV Rise in U.S. on Low Vaccine Use
Bloomberg

Investing In Cervical Cancer: Merck, Glaxo, And... Inovio?

Investing In Cervical Cancer: Merck, Glaxo, And... Inovio?
Seeking Alpha

Advaxis reports updated Phase 2 cervical cancer trial data

Advaxis reports updated Phase 2 cervical cancer trial data
Yahoo/Fly on the Wall

Advaxis to Report Updated Safety, Tumor Response, and Survival Data from a Phase 2 Trial in Recurrent/Refractory Cervical Cancer at ASCO

Advaxis to Report Updated Safety, Tumor Response, and Survival Data from a Phase 2 Trial in Recurrent/Refractory Cervical Cancer at ASCO
Yahoo/Business Wire

Vaccines alliance nears deal on cervical cancer shots

Vaccines alliance nears deal on cervical cancer shots
Reuters
Submitted by admin on Thu, 12/15/2011 - 20:35

Hologic's cervical cancer device gets FDA nod

Hologic's cervical cancer device gets FDA nod
Reuters
Submitted by moderatorj on Mon, 11/21/2011 - 19:07

UPDATE 1-BSD's cervical cancer device gets FDA nod

UPDATE 1-BSD's cervical cancer device gets FDA nod
Reuters